Tomasz RL

Language: Spanish
References: 10
Page: 151-153
PDF size: 31.11 Kb.

ABSTRACT

Many authors prove through examples of their patients that Sertraline is a most efficient drug well accepted in the treatment of the “major depression” on cancer patients with multiple metastases. We present the case of a trainer of gymnastics.

REFERENCES

1. Aguglia E, Casacchia M, Cassano GB. Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression. International Clinical Psychopharmacology 1993; 8(3): 197-202.

2. Finkel SL, Richter EM, Clary CM. Comparative efficiency and safety of sertraline versus nortriptyline in major depression in patients 70 and older. International Psychogeriatrics 1999; 11(l): 85-99.

3. Keller MB, Gelenberg AJ Hirschfeld RM. The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine. Journal of Clinical Psychiatry 1998; 59(11): 598-607.

4. Keller MB, Harrison W, Fawcett JA. Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of under treatment in the community. Psychopharmacology Bulletin 1995; 31(2): 205-12.

5. Kirli S, Caliskan M. A comparative study of sertraline versus imipramine in post psychotic depressive disorder of schizophrenia. Schizophrenia Research 1998; 33: 1-2.

6. Moller HJ, Gallinat J, Hegerl U. Double-blind, multicenter comparative study of sertraline and amitriptyline in hospitalized patients with major depression. Pharmacopsychiatry 1998; 31(6): 170-7.

7. Murdoch D, McTavish D. Sertraline. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in depression and obsessive compulsive disorder. [Review] [72 refs]. Drugs 1992; 44(4): 604-24.

8. Oinan TG. Lithium augmentation in sertraline —resistant depression: a preliminary dose— response study. Psychiatrica Scandinavica 1993; 88(4): 300-1.

9. Preskorn SH, Lane RM. Sertraline 50 mg daily: the optimal dose in the treatment of depression. [Review] [55 refs]. International Clinical Psychopharmacology 1996; 10(3): 129-41.

10. Shapiro PA, Lesperance F, Frasure-Smith N. An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction.